Alpro Foundation   Report issue

Foundation
Founded: Wevelgem Belgium (1996)

Organization Overview

First Clinical Trial
2010
NCT01292954
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Alpro Foundation

Active Ingredients

Drugs in Other Trials (4)

blueberry (1 trial)

blueberry allergenic extract (1 trial)

l-epigallocatechin (1 trial)

soybean (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 4